World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
112
Citations
53823
World Ranking
446
National Ranking
21

Medicine

D-Index
112
Citations
53989
World Ranking
5100
National Ranking
282

Bernhard Hemmer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Bernhard Hemmer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 568 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Bernhard Hemmer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Bernhard Hemmer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 112 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Bernhard Hemmer is a researcher affiliated with the Technical University of Munich in Germany. The primary field of their work is Medicine, with a significant focus on subfields such as Pathology and Forensic Medicine, Neurology, Immunology, Rheumatology, and Molecular Biology.

The scientist's research topics include multiple areas within neurology and immunology, particularly concentrating on:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Systemic Lupus Erythematosus Research
  • T-cell and B-cell Immunology
  • Polyomavirus and related diseases
  • Neuroinflammation and Neurodegeneration Mechanisms
  • SARS-CoV-2 and COVID-19 Research

Among recent significant publications, the following papers stand out:

  • "Myelin-oligodendrocyte glycoprotein antibody-associated disease" (2021) published in The Lancet Neurology
  • "Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS" (2020) published in Nature Communications
  • "Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms" (2020) published in Journal of the Neurological Sciences
  • "Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management" (2023) published in Journal of Neurology
  • "Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study" (2020) published in EBioMedicine

Bernhard Hemmer has frequently published in several scientific venues, including:

  • Multiple Sclerosis Journal
  • Neurology Neuroimmunology & Neuroinflammation
  • Journal of Neurology
  • Neurology
  • European Journal of Neurology

The researcher collaborates frequently with a number of coauthors, among the most prominent are:

  • Achim Berthele
  • Mark Mühlau
  • Jan S. Kirschke
  • Christiane Gasperi
  • Claus Zimmer

Best Publications

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

    Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni

  • Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold

  • Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

    Unknown

  • Multiple sclerosis

    Unknown

  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  • An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis

    Paul Schmidt;Christian Gaser;Milan Arsic;Dorothea Buck

  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

    X. Montalban;R. Gold;A. J. Thompson;S. Otero‐Romero

  • A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

    Charlotte Teunissen;Axel Petzold;Jeffrey L. Bennett;Frode S. Berven

  • Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

    Sven Jarius;Klemens Ruprecht;Brigitte Wildemann;Tania Kuempfel

  • New concepts in the immunopathogenesis of multiple sclerosis.

    Bernhard Hemmer;Juan J. Archelos;Hans-Peter Hartung

  • Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis

    Unknown

  • Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

    Markus Krumbholz;Diethilde Theil;Sabine Cepok;Bernhard Hemmer

  • Role of the innate and adaptive immune responses in the course of multiple sclerosis

    Bernhard Hemmer;Martin Kerschensteiner;Thomas Korn

  • Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica

    Jeffrey L. Bennett;Chiwah Lam;Sudhakar Reddy Kalluri;Philippe Saikali

  • EFNS guidelines on diagnosis and management of neuromyelitis optica

    J. Sellner;M. Boggild;M. Clanet;R.Q. Hintzen

  • TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways.

    Irena Stefanová;Bernhard Hemmer;Marco Vergelli;Roland Martin

  • Immune surveillance in multiple sclerosis patients treated with natalizumab

    Olaf Stüve;Olaf Stüve;Christina M Marra;Keith R Jerome;Keith R Jerome;Keith R Jerome;Linda Cook;Linda Cook;Linda Cook

  • Myelin-oligodendrocyte glycoprotein antibody-associated disease.

    Romain Marignier;Romain Marignier;Yael Hacohen;Alvaro Cobo-Calvo;Anne Katrin Pröbstel

  • Acute disseminated encephalomyelitis: an update.

    Til Menge;Bernhard Hemmer;Stefan Nessler;Heinz Wiendl

  • Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic T H 17 cells

    Sylvia Heink;Nir Yogev;Christoph Garbers;Marina Herwerth

  • Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

    Sabine Cepok;Dun Zhou;Rajneesh Srivastava;Stefan Nessler

  • Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis

    Sabine Cepok;Berit Rosche;Verena Grummel;Friederike Vogel

  • Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis

    Rajneesh Srivastava;Muhammad Aslam;Sudhakar Reddy Kalluri;Lucas Schirmer

Frequent Co-Authors

Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Olaf Stüve
Olaf Stüve The University of Texas Southwestern Medical Center
Roland Martin
Roland Martin University of Zurich
Thomas Korn
Thomas Korn Technical University of Munich
Bernd C. Kieseier
Bernd C. Kieseier Novartis (Switzerland)
Hayrettin Tumani
Hayrettin Tumani University of Ulm
Frauke Zipp
Frauke Zipp Johannes Gutenberg University of Mainz
Heinz Wiendl
Heinz Wiendl University of Münster
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Friedemann Paul
Friedemann Paul Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology and related healthcare fields, exploring online degree programs can be a practical step toward advancing your career. Programs such as the cheapest online pmhnp certificate programs offer affordable pathways to specialize in mental health, complementing the study of immune system disorders.

Nursing professionals looking to expand their expertise often consider accelerated routes. The accelerated rn to np programs provide an efficient way for registered nurses to become nurse practitioners, opening doors to advanced clinical roles that engage with immunological conditions.

Career advancement may also involve transitioning specialties. For example, the guide on fnp to acute care certification offers insight on moving from family nurse practitioner roles to acute care, a shift relevant for professionals dealing with severe immune-related illnesses.

Lastly, understanding compensation is crucial when planning your career. Resources detailing dnp salary by state help graduates make informed decisions about where to practice and specialize after completing their Doctor of Nursing Practice degree.

Best Scientists Citing Bernhard Hemmer

Trending Scientists

Recently Published Articles